Riskpilot← Back to searchSign inGet full accessASTION PHARMA A/S
A/SActiveCVR 34224781Trævænget 14Other financial service activities, except insurance and pension funding n.e.c. · NACE 6499Est. 20121 employees
Revenue 2025
DKK -18K
-84% vs 2024
EBITDA margin
100.0%
+84% vs 2024
Equity ratio
-760.1%
Financial strength
Net profit 2025
DKK -165K
+33% vs 2024
| Revenue | DKK -18K | -84% |
| EBITDA | DKK -18K | +84% |
| Net profit | DKK -165K | +33% |
| Total assets | DKK 783K | -74% |
| Equity | DKK -6M | -3% |
| Employees | 1 | — |
Legal name
ASTION PHARMA A/S
CVR number
34224781
Legal form
Aktieselskab
NACE code
6499 · Other financial service activities, except insurance and pension funding n.e.c.
Founded
27. januar 2012
Share capital
DKK 500.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af Jan Kruse Hansen, af en direktør i forening med et bestyrelsesmedlem, af to bestyrelsesmedlemmer i forening eller af den samlede bestyrelse.
Company purpose
Selskabets formål er enten selv eller gennem ejerandele i andre selskaber - direkte eller indirekte - at drive virksomhed med forskning, fremstilling og handel inden for medicinsk udstyr, bioteknologi og beslægtede områder samt inden for finansiering og investering og hermed beslægtede områder efter bestyrelsens nærmere skøn.
Address
Trævænget 14
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -1.110 | -804 | -1.242 | -783 | -187 | -48 | -392 | -1.832 | -3.603 | -1.354 | 206 | 132 | -116 | -18 |
| Staff expenses | -292 | -402 | -1.505 | -216 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -1.402 | -1.206 | -2.747 | -6.898 | -187 | -1.956 | -392 | -1.832 | -3.603 | -1.354 | 206 | 132 | -116 | -18 |
| Depreciation & amort. | -6 | -27 | -27 | -23 | -11 | -8 | -0 | -259 | -1.624 | -6.361 | -0 | -0 | -23 | -40 |
| EBIT | -1.408 | -1.233 | -2.774 | -6.921 | -198 | -1.964 | -392 | -2.091 | -5.226 | -7.716 | 206 | 132 | -138 | -58 |
| Net financials | -534 | -1.097 | -1.643 | -748 | 347 | -15 | -125 | -175 | -290 | -332 | -174 | -176 | -178 | -153 |
| Profit before tax | -1.942 | -2.330 | -4.417 | -7.669 | 149 | -1.980 | -518 | -2.265 | -5.517 | -8.048 | 32 | -43 | -316 | -211 |
| Tax | -0 | -822 | -981 | -1.900 | 33 | -436 | -108 | -498 | -709 | -1.775 | 7 | -54 | -69 | -46 |
| Net profit | -1.942 | -1.509 | -3.436 | -5.768 | 117 | -1.544 | -409 | -1.767 | -4.808 | -6.273 | 25 | 11 | -246 | -165 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 37.189 | 42.303 | 43.546 | 17.403 | 16.856 | 10.800 | 10.665 | 11.501 | 10.516 | 3.588 | 2.992 | 2.966 | 2.986 | 783 |
| Equity | 26.265 | 24.756 | 21.320 | 15.551 | 15.668 | 7.681 | 7.272 | 5.505 | 697 | -5.576 | -5.550 | -5.539 | -5.786 | -5.950 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 602 | 626 | 638 | 651 | 664 | 678 |
| Short-term debt | 10.925 | 17.547 | 22.205 | 1.852 | 1.189 | 3.119 | 3.394 | 5.996 | 9.217 | 8.538 | 7.904 | 7.854 | 8.107 | 6.056 |
| Total debt | 10.925 | 17.547 | 22.205 | 1.852 | 1.189 | 3.119 | 3.394 | 5.996 | 9.819 | 9.164 | 8.542 | 8.505 | 8.771 | 6.733 |
EBITDA margin
-1807100.0%
This company
15.8%
Market median
-11437442% vs market
20122025
Equity ratio
-760.1%
This company
38.2%
Market median
-2090% vs market
20122025
Return on equity
-16473600.0%
This company
18.4%
Market median
-89530535% vs market
20122025
Net profit margin
-16473600.0%
This company
8.1%
Market median
-203377878% vs market
20122025
Asset turnover
-0.02×
This company
1.12×
Market median
-102% vs market
20122025
Debt / equity
1.13×
This company
0.62×
Market median
-82% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-27 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JK Management | Management | 2018 | — | — |
MB Management | Management | 2018 | — | — |
MW Management | Management | 2012 | — | — |
MJ Management | Management | 2014 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2015 | — | — | |
| Board of Directors | 2012 | — | — | |
| Chairman | 2012 | — | — | |
| Board of Directors | 2015 | — | — | |
| Chairman | 2012 | — | — | |
| Board of Directors | 2018 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
KAPITALFORMIDLINGS INSTITUTTET A/S | Company | 50.0% | 50.0% | 2020 |
MFCM ApS | Company | 10.0% | 10.0% | 2018 |
ØSTERBY & KRUSE ApS | Company | 10.0% | 10.0% | 2020 |
NOITSA ApS | Company | 10.0% | 10.0% | 2020 |
Dansk Generationsskifte A/S | Company | 5.0% | 5.0% | 2020 |
JAKH Holding IVS | Company | 10.0% | 10.0% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
KAPITALFORMIDLINGS INSTITUTTET A/S
ASTION PHARMA A/S Board members of ASTION PHARMA A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Kruse Hansen | Management | 0 companies |
| Morten Bo Madsen | Management | 0 companies |
| Morten Weidner | Management | 0 companies |
| Morten Just Petersen | Management | 0 companies |
| Torben Rønje | Chairman | 0 companies |
| Jens Heimburger | Board of Directors | 0 companies |
| Flemming Ørnskov | Chairman | 0 companies |
| Torben Holger Schultz | Board of Directors | 0 companies |
| Søren Fjelrad Andersen | Chairman | 0 companies |
| Ib Henrik Rønje | Board of Directors | 0 companies |